Marginal zone lymphoma
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
Updates to Article Attributes
Marginal zone lymphomas are a group of low grade non-Hodgkin lymphoma that arise from the marginal zone of B cell germinal follicles in lymph nodes. There are three types of marginal zone lymphomas depending on the site of origin, namely mucosa-accosiated lymphoid tissue (MALT), splenic and extranodal marginal lymphoma.
Epidemiology
MALT lymphomas are the most common type of marginal zone lymphoma with an annual incidence of 5-8%. The most common sites among MALT lymphomas are the stomach and thyroid. Stomach MALT lymphomas are associated with H. pylori infection. Extranodal and splenic marginal zone lymphomas are rare and form approximately 1% of all NHL 1. There is an increased incidence in patients over the age of 60 years.
Clinical presentation
Clinical presentation is highly variable depending on site and origin of disease, with potential symptoms including:
gastro-oesophageal reflux
epigastric pain
eye redness (if involvement of ocular adnexa)
unilateral salivary gland enlargement
diarrhoea
colicky abdominal pain (if involvement of intestines)
cough (if pulmonary involvement) 2
Pathology
The most commonly reported genetic abnormalities are t(11,18) and trisomy 3.
Microscopic appearance
On histology, marginal zone hyperplasia and involvement of the interfollicular zone with malignant cells is seen. The malignant cells are of B cell origin 3.
Associations
Radiographic features
The imaging findings of marginal zone lymphomas depend on the site or origin at their corresponding stage.
In abdominal involvement, enlargement of the para-aortic, retroperitoneal and mesenteric lymph nodes is often seen. The 'floating aorta' sign may also be seen.
In the chest, mediastinal lymph node enlargement is seen.
Compression of the dural sac by an extradural mass can also be seen.
PET imaging reveals increased FDG uptake in the affected lymph nodes 4,5.
Treatment and prognosis
In cases of gastric MALT lymphoma, H. pylori eradication is often indicated.
Locoregional radiotherapy is often first line for low stage disease.
If chemotherapy is indicated, regimens such as rituximab, cyclophosphamide, vincristine and prednisolone (R-CVP) are used 4.
See also
-<li>gastro-oesophageal reflux</li>-<li>epigastric pain</li>-<li>eye redness (if involvement of ocular adnexa)</li>-<li>unilateral salivary gland enlargement</li>-<li>diarrhoea</li>-<li>colicky abdominal pain (if involvement of intestines)</li>-<li>cough (if pulmonary involvement) <sup>2</sup>-</li>-</ul><h4>Pathology</h4><p>The most commonly reported genetic abnormalities are t(11,18) and trisomy 3.</p><p>On histology, marginal zone hyperplasia and involvement of the interfollicular zone with malignant cells is seen. The malignant cells are of B cell origin <sup>3</sup>.</p><h4>Radiographic features</h4><p>The imaging findings of marginal zone lymphomas depend on the site or origin at their corresponding stage. </p><p>In abdominal involvement, enlargement of the para-aortic, retroperitoneal and mesenteric lymph nodes is often seen. The '<a href="/articles/floating-aorta-sign">floating aorta</a>' sign may also be seen.</p><p>In the chest, mediastinal lymph node enlargement is seen. </p><p>Compression of the dural sac by an extradural mass can also be seen. </p><p>PET imaging reveals increased FDG uptake in the affected lymph nodes <sup>4,5</sup>.</p><h4>Treatment and prognosis</h4><p>In cases of gastric MALT lymphoma, <em>H. pylori</em> eradication is often indicated. </p><p>Locoregional radiotherapy is often first line for low stage disease. </p><p>If chemotherapy is indicated, regimens such as rituximab, cyclophosphamide, vincristine and prednisolone (R-CVP) are used <sup>4</sup>.</p><h4>See also</h4><ul><li><a href="/articles/malt-lymphoma">MALT lymphoma</a></li></ul>- +<li><p>gastro-oesophageal reflux</p></li>
- +<li><p>epigastric pain</p></li>
- +<li><p>eye redness (if involvement of ocular adnexa)</p></li>
- +<li><p>unilateral salivary gland enlargement</p></li>
- +<li><p>diarrhoea</p></li>
- +<li><p>colicky abdominal pain (if involvement of intestines)</p></li>
- +<li><p>cough (if pulmonary involvement) <sup>2</sup></p></li>
- +</ul><h4>Pathology</h4><p>The most commonly reported genetic abnormalities are t(11,18) and trisomy 3.</p><h5>Microscopic appearance</h5><p>On histology, marginal zone hyperplasia and involvement of the interfollicular zone with malignant cells is seen. The malignant cells are of B cell origin <sup>3</sup>.</p><h5>Associations</h5><ul><li><p><a href="/articles/hepatitis-c-virus" title="Hepatitis C virus">hepatitis C viral infection</a> <sup>6</sup></p></li></ul><h4>Radiographic features</h4><p>The imaging findings of marginal zone lymphomas depend on the site or origin at their corresponding stage. </p><p>In abdominal involvement, enlargement of the para-aortic, retroperitoneal and mesenteric lymph nodes is often seen. The '<a href="/articles/floating-aorta-sign">floating aorta</a>' sign may also be seen.</p><p>In the chest, mediastinal lymph node enlargement is seen. </p><p>Compression of the dural sac by an extradural mass can also be seen. </p><p>PET imaging reveals increased FDG uptake in the affected lymph nodes <sup>4,5</sup>.</p><h4>Treatment and prognosis</h4><p>In cases of gastric MALT lymphoma, <em>H. pylori</em> eradication is often indicated. </p><p>Locoregional radiotherapy is often first line for low stage disease. </p><p>If chemotherapy is indicated, regimens such as rituximab, cyclophosphamide, vincristine and prednisolone (R-CVP) are used <sup>4</sup>.</p><h4>See also</h4><ul><li><p><a href="/articles/malt-lymphoma">MALT lymphoma</a></p></li></ul>
References changed:
- 1. Ferreri A & Zucca E. Marginal-Zone Lymphoma. Crit Rev Oncol Hematol. 2007;63(3):245-56. <a href="https://doi.org/10.1016/j.critrevonc.2007.04.009">doi:10.1016/j.critrevonc.2007.04.009</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/17583528">Pubmed</a>
- 3. Khalil M, Morton L, Devesa S et al. Incidence of Marginal Zone Lymphoma in the United States, 2001-2009 with a Focus on Primary Anatomic Site. Br J Haematol. 2014;165(1):67-77. <a href="https://doi.org/10.1111/bjh.12730">doi:10.1111/bjh.12730</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/24417667">Pubmed</a>
- 4. Auer I, Gascoyne R, Connors J et al. T(11;18)(q21;q21) is the Most Common Translocation in MALT Lymphomas. Ann Oncol. 1997;8(10):979-85. <a href="https://doi.org/10.1023/a:1008202303666">doi:10.1023/a:1008202303666</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/9402171">Pubmed</a>
- 5. A. Victor Hoffbrand, Paul A. H. Moss. Hoffbrand's Essential Haematology. (2015) ISBN: 9781118408674 - <a href="http://books.google.com/books?vid=ISBN9781118408674">Google Books</a>
- 6. Maksimovic O, Bethge W, Pintoffl J et al. Marginal Zone B-Cell Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue Type: Imaging Findings. AJR Am J Roentgenol. 2008;191(3):921-30. <a href="https://doi.org/10.2214/AJR.07.2629">doi:10.2214/AJR.07.2629</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/18716129">Pubmed</a>
- 2. Armand M, Besson C, Hermine O, Davi F. Hepatitis C Virus - Associated Marginal Zone Lymphoma. Best Pract Res Clin Haematol. 2017;30(1-2):41-9. <a href="https://doi.org/10.1016/j.beha.2017.02.001">doi:10.1016/j.beha.2017.02.001</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/28288715">Pubmed</a>
- 1. Ferreri AJ, Zucca E. Marginal-zone lymphoma. (2007) Critical reviews in oncology/hematology. 63 (3): 245-56. <a href="https://doi.org/10.1016/j.critrevonc.2007.04.009">doi:10.1016/j.critrevonc.2007.04.009</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/17583528">Pubmed</a> <span class="ref_v4"></span>
- 2. Mohammad O. Khalil, Lindsay M. Morton, Susan S. Devesa, David P. Check, Rochelle E. Curtis, Dennis D. Weisenburger, Graça M. Dores. Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site. (2014) British Journal of Haematology. 165 (1): 67. <a href="https://doi.org/10.1111/bjh.12730">doi:10.1111/bjh.12730</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/24417667">Pubmed</a> <span class="ref_v4"></span>
- 3. Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, Sanger WG, Horsman DE. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. (1997) Annals of oncology : official journal of the European Society for Medical Oncology. 8 (10): 979-85. <a href="https://www.ncbi.nlm.nih.gov/pubmed/9402171">Pubmed</a> <span class="ref_v4"></span>
- 4. A. Victor Hoffbrand, Paul A. H. Moss. Hoffbrand's Essential Haematology. (2015) <a href="https://books.google.co.uk/books?vid=ISBN9781118408674">ISBN: 9781118408674</a><span class="ref_v4"></span>
- 5. Maksimovic O, Bethge WA, Pintoffl JP, Vogel M, Claussen CD, Bares R, Horger M. Marginal zone B-cell non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type: imaging findings. (2008) AJR. American journal of roentgenology. 191 (3): 921-30. <a href="https://doi.org/10.2214/AJR.07.2629">doi:10.2214/AJR.07.2629</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/18716129">Pubmed</a> <span class="ref_v4"></span>
Tags changed:
- mzl
Image 7 MRI (renal parenchymal phase) ( create )
Unable to process the form. Check for errors and try again.